ITDC India e-Press / Agencies

BMHRC and Shyam Shah Medical College Sign Pact to Strengthen Sickle Cell Prevention and Treatment

CNN Central News & Networks / ITDC India Epress / ITDC News / Bhopal: In a significant step towards preventing sickle cell disease and other haemoglobinopathies, improving early detection, promoting prenatal diagnosis, treatment and research, the ICMR-Bhopal Memorial Hospital and Research Centre (BMHRC) has signed a Memorandum of Understanding (MoU) with the Birsa Munda Centre of Excellence for Prenatal Diagnosis of Haemoglobinopathies at Shyam Shah Medical College, Rewa. The agreement was signed in the presence of Madhya Pradesh Deputy Chief Minister Rajendra Shukla.

The MoU was signed by Dr. Prof. Manisha Srivastava, Director and Nodal Officer of the Sickle Cell Competence Centre at BMHRC, and Dr. Prof. Binu Kushwaha Singh, Project Head and Nodal Officer of the Birsa Munda Centre of Excellence at Shyam Shah Medical College. Dr. Abhijit Deshmukh was also present.

The primary objective is to improve healthcare services for people affected by sickle cell disease and high-risk families, particularly in tribal-dominated areas of Madhya Pradesh, and accelerate the goals of the Government of India's National Sickle Cell Anaemia Elimination Mission.

Under the agreement, gynaecologists, nursing staff, paramedical personnel, ANMs and ASHA workers in tribal districts will receive training and capacity-building support, along with continued technical guidance.

The Birsa Munda Centre of Excellence, described as the country's first training centre of its kind, will facilitate screening of pregnant women and high-risk couples, disease identification, genetic counselling and referrals for advanced testing. BMHRC will support confirmatory diagnosis through HPLC, PCR and DNA-based technologies, as well as prenatal diagnosis through procedures such as chorionic villus sampling (CVS) and amniocentesis. An AI-based skill laboratory is also planned for the future.

Both institutions will coordinate specialist treatment for affected mothers and newborns, including blood transfusions and bone marrow transplantation wherever required. They will also collaborate on research and improving healthcare quality.

Eligible beneficiaries will be provided testing, prenatal diagnosis and genetic counselling free of cost or at concessional rates, as per applicable government schemes and guidelines. The MoU will initially remain in force for two years, with a joint committee reviewing progress every three months.


Hashtags: #MadhyaPradeshState #Bhopal #Bmhrc #Shyam #Shah #Medical #College #Sign #Pact #BMHRCAndShyamShah